✦ LIBER ✦

Current Literature: Fas-mediated therapy for autoimmune disease.

✍ Scribed by K. McCormack

Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 78 KB
Volume: 20
Category: Article
ISSN: 0167-5699
DOI: 10.1016/s0167-5699(99)01453-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thyrotropin-receptor-mediated diseases:

Thyrotropin-receptor-mediated diseases: a paradigm for receptor autoimmunity

✍ Bellur S. Prabhakar; Ji-Lao Fan; Gattadahalli S. Seetharamaiah 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Autoantibodies to the thyrotropin receptor (TSHR) can act as thyrotropin agonists or antagonists, or can cause thyroid hypertrophy. Neither the autoantibody-binding sites on the TSHR nor the intracellular mechanisms by which the autoantibodies mediate their diverse functional effects are completely

New prospects for autoimmune disease the

New prospects for autoimmune disease therapy: B cells on deathwatch

✍ E. William St.Clair; Thomas F. Tedder 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 2 views

Dr. St.Clair has served on the advisory boards of Genentech, Cellective Therapeutics (now owned by MedImmune), and Human Genome Sciences. Dr. Tedder has Tedder has received consulting fees (more than $10,000 per year) from Cellective Therapeutics (now owned by MedImmune), has given expert testimony

Could specific oral tolerance be a thera

Could specific oral tolerance be a therapy for autoimmune disease?

✍ H Stephen; G Thompson; Norman A Staines 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 633 KB

B cell–ablative therapy for the treatmen

B cell–ablative therapy for the treatment of autoimmune diseases

✍ Dhavalkumar D. Patel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Emerging approaches for the therapy of a

Emerging approaches for the therapy of autoimmune and chronic inflammatory disease

✍ Andrew P Cope; Marc Feldmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Antigen-specific blocking of CD4-Specifi

Antigen-specific blocking of CD4-Specific immunological synapse formation using BPI and current therapies for autoimmune diseases

✍ Prakash Manikwar; Paul Kiptoo; Ahmed H. Badawi; Barlas Büyüktimkin; Teruna J. Si 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract In this review, we discuss T‐cell activation, etiology, and the current therapies of autoimmune diseases (i.e., MS, T1D, and RA). T‐cells are activated upon interaction with antigen‐presenting cells (APC) followed by a “bull's eye”‐like formation of the immunological synapse (IS) at the